Orthofix Medical Inc.: ARMISTICE CAPITAL, LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Armistice Capital LLC disclosed a stake exceeding 5% in Orthofix Medical Inc. via a Schedule 13G filing with the SEC (accession 0001172661-26-005278). The exact share count and percentage were not specified in the filing headline. The disclosure signals active institutional ownership in the medical device maker and could prompt investor scrutiny of Armistice's intentions. Watch for further 13G/13D amendments or proxy activity that clarify whether the position is passive or activist.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Armistice Capital, LLC, Orthofix Medical Inc.